Eurobio Scientific: EXCEPTIONAL 2020 TURNOVER OF € 189 MILLION (+ 220%)

    NEXT STORY
    UCSF QBI and Icahn School of Medicine at Mount Sinai Scientists Report New Preclinical Data Published in Science on Potential Best-in-Class COVID-19 Anti-Viral Treatment: Plitidepsin
    PREV STORY
    Atossa Therapeutics President and CEO Dr. Steven C. Quay to Speak at Precision Medicine World Conference, Spotlighting Anthony S. Fauci, MD, Director NIAID January 25-27, 2021
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    ChromaDex Establishes $5 Million Credit Facility with Bridge Bank

    IRVINE, Calif., Nov. 08, 2016 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of ...

    author_avatar
    NASDAQ Market News

    MDA Awards $300,000 to Streamline Gathering of Data for ALS Research

    Chicago, June 15, 2017 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association has announced the ...

    author_avatar
    NASDAQ Market News

    AMAG Pharmaceuticals Announces Closing of Exclusive Licensing Agreement for North American Rights to Rekynda™ (bremelanotide)

    WALTHAM, Mass., Feb. 03, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) announced today ...

    author_avatar
    NASDAQ Market News